Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Large-scale testing (Phase 3)Study completedNCT06588283
What this trial is testing

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

Who this might be right for
PsoriasisObesity
Eli Lilly and Company 281
Testing effectiveness (Phase 2)Looking for participantsNCT07719530
What this trial is testing

Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis

Who this might be right for
Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 60
Post-approval studies (Phase 4)Ended earlyNCT04339595
What this trial is testing

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 47
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Not applicableUnknownNCT03817164
What this trial is testing

Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Thync Global, Inc. 110
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Post-approval studies (Phase 4)Study completedNCT02412644
What this trial is testing

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Psoriasis Treatment Center of Central New Jersey 29
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Early research (Phase 1)UnknownNCT03710681
What this trial is testing

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 16
Large-scale testing (Phase 3)WithdrawnNCT01815723
What this trial is testing

Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH
Large-scale testing (Phase 3)Study completedNCT04728360
What this trial is testing

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 556
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT03757013
What this trial is testing

Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France

Who this might be right for
Psoriasis
Amgen 453
Testing effectiveness (Phase 2)Study completedNCT01831466
What this trial is testing

Tofacitinib Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPsoriasis
Pfizer 476
Testing effectiveness (Phase 2)Study completedNCT05364554
What this trial is testing

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 227
Testing effectiveness (Phase 2)Study completedNCT01107457
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 142
Testing effectiveness (Phase 2)UnknownNCT04117919
What this trial is testing

Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath

Who this might be right for
Psoriasis
China Medical University Hospital 30
Large-scale testing (Phase 3)Study completedNCT03897075
What this trial is testing

Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Nail Psoriasis
Sun Pharmaceutical Industries Limited 99
Testing effectiveness (Phase 2)Study completedNCT01987843
What this trial is testing

Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Tanabe Pharma Corporation 142
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation